Skip to content

Endoscopic Versus Conventional Parotidectomy for Benign Parotid Tumors

Endoscopic Versus Conventional Parotidectomy in the Management of Benign Parotid Tumors : A Prospective Comparative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07600112
Acronym
miniparo
Enrollment
46
Registered
2026-05-20
Start date
2026-05-01
Completion date
2028-06-01
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parotidectomy

Keywords

parotidectomy

Brief summary

To compare endoscopic and conventional parotidectomy in the management of benign parotid tumors regarding surgical outcomes, facial nerve preservation, operative time, postoperative complications, and cosmetic results, in order to evaluate the safety, feasibility, and potential advantages of the endoscopic minimally invasive technique.

Detailed description

Parotid gland tumors account for approximately 3-6% of all head and neck tumors, and nearly 70-80% arise from the superficial lobe of the gland, with the majority being benign lesions such as pleomorphic adenoma and Warthin tumor . A considerable proportion of these tumors occur in the inferior pole of the parotid gland, where surgical management aims to achieve complete tumor excision while preserving facial nerve function and maintaining satisfactory cosmetic outcomes . Conventional parotidectomy performed through a modified Blair incision remains the standard surgical approach for benign parotid tumors . This technique offers adequate surgical exposure and good tumor control; however, it is associated with several limitations including visible facial scarring, potential facial nerve injury, Frey's syndrome, and postoperative sensory disturbances . In recent years, minimally invasive surgical approaches have been introduced to overcome these limitations. Endoscopic parotidectomy has emerged as a promising technique for selected benign parotid tumors. The magnified endoscopic view may facilitate more precise dissection and improved identification of facial nerve branches while allowing smaller incisions and potentially better cosmetic outcomes . Despite encouraging results reported in several studies, the available evidence comparing endoscopic parotidectomy with the conventional approach remains limited. Therefore, further prospective comparative studies are required to evaluate the safety, efficacy, and cosmetic advantages of this minimally invasive technique.

Interventions

PROCEDUREEndoscopic Parotidectomy Group

Minimally invasive endoscopic-assisted parotidectomy performed through anterior chest wall approach for benign parotid tumors.

PROCEDUREActive Comparator Intervention Conventional Parotidectomy

Conventional open parotidectomy performed through modified Blair incision for management of benign parotid tumors.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

prospective randomized controlled parallel assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults aged 18 years or older 2. Patients with benign parotid tumors involving the superficial lobe of the parotid gland 3. Tumors located in the inferior pole with or without limited deep lobe extension 4. Tumor size suitable for minimally invasive approach ≤4 cm 5. Patients fit for surgery under general anesthesia 6. Patients willing to provide informed consent and comply with follow-up

Exclusion criteria

1. Recurrent parotid tumors 2. Previous parotid surgery on the affected side 3. Pre-existing facial nerve dysfunction 4. Previous neck surgery or extensive cervical/anterior chest wall scarring 5. Significant comorbidities contraindicating surgery or general anesthesia 6. Suspected or confirmed malignant parotid tumors

Design outcomes

Primary

MeasureTime frameDescription
Surgical safety and feasibilityDuring surgery and up to 3 months postoperatively.Assessment of intraoperative and postoperative complications and conversion rate to open surgery.
Facial nerve function24 hours, 1 week, 1 month, and 3 months postoperatively.Assessment using House-Brackmann grading system.

Secondary

MeasureTime frame
Intraoperative blood lossIntraoperative

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026